CAC Nantong Chemical Co., Ltd. (SHE:301665)
China · Delayed Price · Currency is CNY 27.45
-0.05 (-0.18%)
Apr 30, 2026, 3:04 PM CST
CAC Nantong Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 5,714 | 5,369 | 4,215 | 3,821 | 5,078 | 3,572 |
Other Revenue | - | - | 21.56 | 47.69 | 20.66 | 7.15 |
| 5,714 | 5,369 | 4,236 | 3,868 | 5,099 | 3,579 | |
Revenue Growth (YoY) | 29.93% | 26.73% | 9.51% | -24.14% | 42.47% | 17.03% |
Cost of Revenue | 4,157 | 3,933 | 3,348 | 2,953 | 3,740 | 2,671 |
Gross Profit | 1,557 | 1,436 | 887.97 | 915.36 | 1,359 | 907.79 |
Selling, General & Admin | 490.52 | 477.34 | 317.28 | 295.65 | 297.87 | 230.83 |
Research & Development | 196.05 | 178.72 | 144.04 | 145.91 | 179.14 | 118.41 |
Other Operating Expenses | 2.43 | 1.67 | 16.02 | 16.33 | 15.07 | 14.46 |
Operating Expenses | 690.89 | 660.83 | 502.4 | 451.14 | 502.81 | 371.64 |
Operating Income | 866.18 | 775.27 | 385.57 | 464.21 | 856.19 | 536.14 |
Interest Expense | -70.45 | -68.72 | -65.82 | -62.23 | -63.81 | -39.64 |
Interest & Investment Income | 8.6 | 6.85 | 2.03 | 4.32 | 2.93 | 11.57 |
Currency Exchange Gain (Loss) | - | - | 21.38 | 22.56 | 50.48 | -18.82 |
Other Non Operating Income (Expenses) | -29.57 | -1.23 | -3.95 | -2.81 | -4.46 | -3.56 |
EBT Excluding Unusual Items | 774.76 | 712.17 | 339.21 | 426.05 | 841.32 | 485.69 |
Gain (Loss) on Sale of Investments | 2.19 | 0.31 | -7.59 | -16.95 | -40.27 | 1.23 |
Gain (Loss) on Sale of Assets | -1.58 | -1.14 | -0.92 | -1.8 | -7.15 | -4.01 |
Asset Writedown | -2.26 | -3.6 | - | - | -12.77 | - |
Other Unusual Items | - | - | -7.13 | -25.7 | -11.65 | -0.47 |
Pretax Income | 773.11 | 707.73 | 323.56 | 381.6 | 769.48 | 482.45 |
Income Tax Expense | 108.32 | 93.34 | 32.81 | 43.81 | 107.93 | 51.73 |
Earnings From Continuing Operations | 664.79 | 614.39 | 290.75 | 337.79 | 661.55 | 430.72 |
Minority Interest in Earnings | -143.54 | -148.64 | -24.81 | 8.68 | -12.43 | -32.78 |
Net Income | 521.25 | 465.75 | 265.94 | 346.48 | 649.13 | 397.93 |
Net Income to Common | 521.25 | 465.75 | 265.94 | 346.48 | 649.13 | 397.93 |
Net Income Growth | 78.24% | 75.13% | -23.24% | -46.62% | 63.12% | 1.18% |
Shares Outstanding (Basic) | 444 | 435 | 403 | 403 | 406 | 406 |
Shares Outstanding (Diluted) | 444 | 435 | 403 | 403 | 406 | 406 |
Shares Change (YoY) | 9.21% | 8.03% | 0.01% | -0.70% | -0.09% | 0.14% |
EPS (Basic) | 1.17 | 1.07 | 0.66 | 0.86 | 1.60 | 0.98 |
EPS (Diluted) | 1.17 | 1.07 | 0.66 | 0.86 | 1.60 | 0.98 |
EPS Growth | 63.20% | 62.12% | -23.26% | -46.25% | 63.27% | 1.03% |
Free Cash Flow | 204.05 | -90.45 | -575.49 | -225.69 | -134.1 | -393.79 |
Free Cash Flow Per Share | 0.46 | -0.21 | -1.43 | -0.56 | -0.33 | -0.97 |
Dividend Per Share | - | - | 0.400 | - | - | 0.750 |
Gross Margin | 27.25% | 26.75% | 20.96% | 23.66% | 26.65% | 25.36% |
Operating Margin | 15.16% | 14.44% | 9.10% | 12.00% | 16.79% | 14.98% |
Profit Margin | 9.12% | 8.67% | 6.28% | 8.96% | 12.73% | 11.12% |
Free Cash Flow Margin | 3.57% | -1.69% | -13.58% | -5.83% | -2.63% | -11.00% |
EBITDA | 1,130 | 1,034 | 624.72 | 686.23 | 1,057 | 696.46 |
EBITDA Margin | 19.77% | 19.26% | 14.75% | 17.74% | 20.72% | 19.46% |
D&A For EBITDA | 263.39 | 258.54 | 239.15 | 222.02 | 200.59 | 160.32 |
EBIT | 866.18 | 775.27 | 385.57 | 464.21 | 856.19 | 536.14 |
EBIT Margin | 15.16% | 14.44% | 9.10% | 12.00% | 16.79% | 14.98% |
Effective Tax Rate | 14.01% | 13.19% | 10.14% | 11.48% | 14.03% | 10.72% |
Revenue as Reported | 5,714 | 5,369 | 4,236 | 3,868 | - | - |
Advertising Expenses | - | - | 7.36 | 7.2 | 2.62 | 2.72 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.